Answers are grounded in this paper and cite their sources.
Fibrin/fibrinogen degradation product (FDP) was measured in 270 cases with various carcinomas. An elevation of FDP (5 micrograms/ml or more) was observed in 68 cases (25%). Of the 68 elevated FDP cases, 5 (82%) were inoperable or received nonradical resection. Forty of those 56 cases (71%) showed hematogenous metastasis. FDP in those cases which showed hematogenous metastasis was found to be due to fibrinolysis accompanied by consumption coagulopathy.
No takes yet. Share an insight, caveat, or question.
Imaoka et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: